Biopath Lab Holdings
Photos
Bio-Path Lab Holdings is an oncology-focused biotechnology company based in Riverside, CA, dedicated to developing innovative DNA therapeutics aimed at directly targeting cancer cells. Leveraging its proprietary DNAbilize platform technology, the company strives to provide effective cancer treatments with minimal side effects, particularly for fragile patients who cannot tolerate traditional chemotherapy.
The company's lead candidate, prexigebersen, is currently in a Phase 2 trial for acute myeloid leukemia, while other products like BP1001-A and BP1002 are under investigation for advanced solid tumors and lymphoma, respectively. Bio-Path's pipeline showcases a commitment to addressing the urgent need for non-toxic therapies in the treatment of lethal blood cancers and solid tumors.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.